Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine

TOKYO, Apr 10, 2024 – (JCN Newswire via – Mitsubishi Shipbuilding Co., Ltd., a part of Mitsubishi Heavy Industries (MHI) Group, has received an order from Japan Engine Corporation (J-ENG) for an ammonia fuel supply system (AFSS) and ammonia gas abatement system (AGAS). Ammonia Fuel Supply System (High-pressure and Low-pressure AFSS module) The AFSS […]

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

TOKYO, Apr 10, 2024 – (JCN Newswire via – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a leader in IT, network and AI technologies, announced that new data will be presented on TG4050, an individualized neoantigen cancer […]

DENSO, Companies Initiate Demonstration to Expand Automotive Recycling Process

KARIYA, JAPAN, Apr 9, 2024 – (JCN Newswire via – DENSO CORPORATION and other partners have been chosen by an industry-government-academia collaborative project aiming to expand the recycle content for automobile in the fiscal year 2023 supported by Ministry of the Environment, Japan. The project, titled “Demonstration of Manufacturing-and-Recycling Integrated Process for Horizontal Cycle* […]

MHI Thermal Systems Adds New KXZ3 Series of Building-use Multi-Split Air- Conditioners Adopting R32 Refrigerant

TOKYO, Apr 9, 2024 – (JCN Newswire via – Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has started mass production of the “KXZ3 Series” of building-use multi-split air-conditioners for its worldwide markets. The newly added lineup, which adopts the R32 refrigerant, is available in […]

NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines

TOKYO, Apr 8, 2024 – (JCN Newswire via – NEC Corporation (TSE: 6701) has released a white paper, “Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines”. This white paper introduces (1) a comprehensive process workflow that can be applied to a wide range of […]

Hitachi Selected as “Excellent TCFD Disclosure” by GPIF’s External Asset Managers for the Third Consecutive Year

Hitachi, Ltd. (TSE: 6501) has been selected as an “excellent TCFD*1 disclosure” from external asset managers entrusted with the Japanese equity investment of Japan’s Government Pension Investment Fund (GPIF) forthe third consecutive year. Hitachi received a high evaluation from eight asset managers, which is the highest number among the selected companies. The reasons for the […]

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics

Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French Overseas Territories and Algeria (the “Territory”) for the antipsychotic, “Loxapac” (generic name: loxapine) and the Parkinson’s disease treatment “Parkinane LP” (generic name: trihexyphenidyl hydrochloride) to CNX Therapeutics Limited. Following the signature […]

Toyota Completes Toyota Technical Center Shimoyama Research and Development Facility for Making Ever-better Cars

Toyota City, Japan, Apr 2, 2024 – (JCN Newswire via – Toyota Motor Corporation (Toyota) announced today that it commenced full operation of its research and development facility, Toyota Technical Center Shimoyama, located in a mountainous area straddling the cities of Toyota and Okazaki, on March 25, 2024. The facility will drive vehicle development […]

Fujitsu signs MoU with Mitsubishi UFJ Financial Group, Inc. to drive nature positive actions

KAWASAKI, Japan, Apr 1, 2024 – (JCN Newswire via – Fujitsu today announced that on March 29, 2024 it concluded a memorandum of understanding with Mitsubishi UFJ Financial Group, Inc. (MUFG) to deliver nature-positive(1) outcomes through the conservation of natural capital and biodiversity. Based on the MoU, Fujitsu will leverage its AI, blockchain, and […]

Embrace Wellness with Your Cherished Canine at Hyatt Regency Hakone Resort & Spa

TOKYO, Apr 1, 2024 – (JCN Newswire via – Conveniently located between Tokyo and Kyoto, Hyatt Regency Hakone Resort & Spa, nestled amidst the abundant nature of Hakone is delighted to announce its new dog-friendly rooms featuring dedicated dog shower facilities and guest bathrooms equipped with “ReFa’s fine bubble shower”. This limited-time offer presents […]

Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA

TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 – (JCN Newswire via – Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the U.S. Food andDrug Administration (FDA) a Supplemental Biologics License Application (sBLA) for monthly lecanemab-irmb (U.S. brand name: LEQEMBI) intravenous (IV) maintenance dosing. LEQEMBI is indicated for the treatment of […]

MHI Concludes Positive Impact Finance Agreement

Mitsubishi Heavy Industries, Ltd. (MHI) has concluded a Positive Impact Finance(1) agreement with Sumitomo Mitsui Trust Bank, Limited (SuMi TRUST Bank) (contract amount: JPY 10.0 billion yen). MHI Group, in response to the growing need to address the global challenge of climate change, in 2020, identified five material issues, including “Provide energy solutions to enable […]

Panasonic Energy and Mazda Enter Agreement Towards Supply of Cylindrical Automotive Lithium-ion Batteries

Osaka and Hiroshima, Japan, Mar 29, 2024 – (JCN Newswire via – Panasonic Energy Co., Ltd., a Panasonic Group Company, and Mazda Motor Corporation today announced they have signed an agreement towards the supply of cylindrical automotive lithium-ion batteries. In June 2023, the two companies commenced discussions aimed at building a medium- to long-term […]

Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical

TOKYO, Mar 29, 2024 – (JCN Newswire via – Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd. Merislon and Myonal […]

Eisai’s Brain Health Self-Check Tool “NouKNOW” is Certified as “ME-BYO BRAND” by Kanagawa Prefecture

TOKYO, Mar 29, 2024 – (JCN Newswire via – Eisai Co., Ltd. announced today that “NouKNOW®”, Eisai’s self-check tool for brain health, was certified as a “ME-BYO BRAND” by Kanagawa prefecture. About ”ME-BYO BRAND” “ME-BYO BRAND”, is a certification granted to excellent products/services associated with pre-symptomatic diseases by Kanagawa Prefectural Government in an effort […]